Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
The dispute between arguably the two biggest names in generative artificial intelligence—billionaires Sam Altman and Elon Musk—erupted this week after President Donald Trump announced a $500 ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act autonomously on the web. But OpenAI is not Altman's ...
Despite this financial boost, OpenAI faces challenges. Earlier this month, Altman said that the company is incurring losses on the ChatGPT Pro plan. The plan, intended to generate revenue ...
OpenAI chief Sam Altman has ... It's not the first time Altman and Musk have publicly sparred with each other online. The pair have a history that goes back to OpenAI's early days.
Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite ...
Trump was joined by Oracle founder Larry Ellison, OpenAI CEO Sam Altman, and SoftBank CEO Masayoshi Son, who said the ...
The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...